Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer

Autoria(s): Hsieh, W.S.; Soo, R.; Peh, B.K.; Loh, T.; Dong, D.F.; Soh, D.; Wong, L.S.; Green, S.; Chiao, J.; Cui, C.Y.; Lai, Y.F.; Lee, S.C.; Mow, B.; Soong, R.; Salto-Tellez, Manuel; Goh, B.C.
Data(s)

01/11/2009
Identificador

http://pure.qub.ac.uk/portal/en/publications/pharmacodynamic-effects-of-seliciclib-an-orally-administered-cell-cycle-modulator-in-undifferentiated-nasopharyngeal-cancer(245e720d-71e1-4825-a15e-c3b61fe6b1e3).html

http://dx.doi.org/10.1158/1078-0432.CCR-08-1748
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Hsieh , W S , Soo , R , Peh , B K , Loh , T , Dong , D F , Soh , D , Wong , L S , Green , S , Chiao , J , Cui , C Y , Lai , Y F , Lee , S C , Mow , B , Soong , R , Salto-Tellez , M & Goh , B C 2009 , ' Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer ' Paper presented at 18th AACR/EORTC/NCI International Conference on Molecular Targets and Cancer Therapeutics , Prague , Czech Republic , 01/11/2009 - 01/11/2009 , pp. 1435-1442 . DOI: 10.1158/1078-0432.CCR-08-1748
Tipo

conferenceObject
Acesso ao item digital